PIEZO1 and cardiac hypertrophy: Our study, combined with recent findings highlighting the role of GOF mutations in murine cardiac hypertrophy and fibrosis (33), suggests that the development of Piezo1-specific inhibitors could potentially reduce atherosclerotic plaque development and may also help alleviate other cardiovascular diseases.